Article

jdsupra.comjdsupra.com on 2018-11-01 11:14

Delaware Found to be Improper Venue for ANDA Suit

The District of Delaware dismissed a Hatch-Waxman Act ANDA lawsuit that Bristol-Myers Squibb had filed against Mylan Pharmaceuticals, finding that ...

Related news